Clinical Trials in Portland

Showing 741-760 of 10,048 trials

Impact of Anatomy-Based Cochlear Implant Programming on Early Performance

NCT06734039

The purpose of this study is to evaluate the impact of different audio processor frequency settings on performance outcomes in new cochlear implant users using electric-only stimulation in the implanted ear with normal hearing to moderately severe hearing loss in the opposite ear.

Hearing Loss, UnilateralCochlear ImplantsHearing Loss, Sensorineural+2 more

Med-El Corporation50 participantsStarted Nov 2025

Iowa City, Iowa, United States • Kansas City, Kansas, United States • Chapel Hill, North Carolina, United States +3 more locations

Active Not RecruitingPhase 2< 1 mile

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

NCT06817356

The objective of this proof-of-concept study to evaluate mazdutide in participants with alcohol use disorder (AUD). For any individual participant, the maximum duration of study participation is approximately 36 weeks, including screening and posttreatment follow-up.

Alcohol Use Disorder

Eli Lilly and Company300 participantsStarted Feb 2025

Scottsdale, Arizona, United States • Rogers, Arkansas, United States • Fountain Valley, California, United States +22 more locations

Impact of Anatomy-Based Cochlear Implant Programming on Early Performance

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Find Trials by Condition in Portland

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Living WELL: A Web-Based Program for Ovarian Cancer Survivors

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer